Newsroom

Industry News

10 Jul

Intec Pharma Appoints U.S. Life Sciences Executive and Vice Chairman Jeffrey A. Meckler as Chief Executive Officer

JERUSALEM, July 10, 2017 /PRNewswire/ — Intec Pharma Ltd. (Nasdaq: NTEC, TASE: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill™ platform technology, announces the appointment of Jeffrey A. Meckler as Chief Executive Officer, effective immediately. Mr. Meckler was named Vice Chairman of the Intec Pharma...

Read more

10 Jul

Youngevity Completes Acquisition of Sorvana International

SAN DIEGO, CA–(Marketwired – Jul 10, 2017) – Youngevity International, Inc. ( NASDAQ : YGYI ), a leading omni-direct lifestyle company, today announced it has closed the acquisition of the assets of Sorvana International. Youngevity originally announced entering into a definitive agreement with Sorvana on June 19 of this year. Sorvana International was formed in...

Read more

10 Jul

Nephros Provides Corporate Update and Second Quarter 2017 Revenue Guidance

RIVER EDGE, NJ–(Marketwired – Jul 10, 2017) –  Nephros, Inc. ( OTCQB : NEPH ) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of patients with End Stage...

Read more

10 Jul

Asterias Biotherapeutics Receives FDA Clearance to Enroll C-4 Patients in SCiStar Study

Ability to enroll patients with second most common cervical spinal cord injury broadens eligible population for SCiStar study and future trials FREMONT, Calif., July 10, 2017 /PRNewswire/ — Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company pioneering the field of regenerative medicine, today announced that the U.S. Food and Drug Administration...

Read more

10 Jul

BioLineRx Announces Initiation of Phase 1b/2 Trial of BL-8040 in Pancreatic Cancer Under Immunotherapy Collaboration

Combination trial of BL-8040 and atezolizumab are part of initiative for the development of novel cancer immunotherapy combinations TEL AVIV, Israel, July 10, 2017 /PRNewswire/ — BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today that Genentech, a member of the Roche Group, has commenced...

Read more

10 Jul

Prima BioMed Announces Approval for the Initiation of the ‘INSIGHT’ Clinical Trial

SYDNEY, Australia, July 09, 2017 (GLOBE NEWSWIRE) — Prima BioMed Ltd (ASX:PRR) (PBMD) (“Prima” the “Company”) today announced that its collaboration partner, the Institute of Clinical Cancer Research, Krankenhaus Nordwest GmbH in Frankfurt Germany (“IKF”), has received the regulatory and ethical approvals for the clinical trial investigating IMP321 in...

Read more

6 Jul

Financial Milestone Achieved in Catalyst’s Subcutaneous Factor IX Program

SOUTH SAN FRANCISCO, Calif., July 06, 2017 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced that it has achieved a financial milestone under its collaboration with ISU Abxis. In June of 2017, the first patient...

Read more

6 Jul

IsoRay Receives FDA Response to 510(k) Application for GammaTile™

RICHLAND, Wash., July 6, 2017 /PRNewswire/ — IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck and gynecological cancers, today announced that it has received a response from the FDA regarding the Company’s...

Read more

Page 3 of 24412345...102030...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address